Kiniksa Pharmaceuticals (KNSA)
(Delayed Data from NSDQ)
$25.27 USD
-0.12 (-0.47%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $25.45 +0.18 (0.71%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/29/2024
Time: -- |
9/2024 | $-0.01 | -275.01% |
Earnings Summary
For their last quarter, Kiniksa Pharmaceuticals (KNSA) reported earnings of -$0.06 per share, beating the Zacks Consensus Estimate of $-0.09 per share. This reflects a positive earnings surprise of 33.33%. Look out for KNSA's next earnings release expected on October 29, 2024. For the next earning release, we expect the company to report earnings of -$0.01 per share, reflecting a year-over-year increase of 95%.
Earnings History
Price & Consensus
Zacks News for KNSA
Zacks.com featured highlights include Kiniksa Pharmaceuticals, HNI, AudioEye, Balchem and The Gorman-Rupp
KNSA: What are Zacks experts saying now?
Zacks Private Portfolio Services